A Study in Non-Small Cell Lung Cancer

Summary

A study to create control arms using current and future information in patients with lung cancer that has spread who have already received chemotherapy.

Eligibility

Inclusion Criteria:

1\. \> 18 years of age at the time of informed consent 2. Pathologically confirmed NSCLC 3 .ECOG Performance of \>1 and fit for further systemic therapy on a NCCN approved regimen (within 4 weeks prior or 14 days after starting second line therapy) 4. Life expectancy of more than 3 months 5. Able to understand and sign informed consent \*see protocol for cohort specific inclusion criteria\*

Exclusion Criteria:

1. Unable to provide informed consent
2. Actively on a clinical trial of an investigational agent
3. Non protocol compliant baseline imaging scan (modality/coverage) prior to index date in patients included after the second or third line therapy has been initiated \*see protocol for cohort specific exclusion criteria\* -

Conditions3

Locations3 sites

Browse More Trials